The University of Texas Medical Branch, Galveston

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, The University of Texas Medical Branch, Galveston sits in the top decile of US sponsors by registered trial count (#152 of 15,742 sponsors by registered trial count).

203 total trials 29 currently recruiting 117 completed early-phase tilt top decile by trial count

The University of Texas Medical Branch, Galveston: 203 sponsored US clinical trials, 29 recruiting.

The University of Texas Medical Branch, Galveston sponsors 203 registered US clinical trials on ClinicalTrials.gov, 29 of them currently recruiting, and 117 completed. 19 of these trials are in Phase 3-4 (later-stage) and 51 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Stroke, with 4 trials.

Top-decile sponsor footprint

The University of Texas Medical Branch, Galveston ranks in the top decile of sponsors by registered trial count (#152 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 25/100

117 of 157 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (74.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

What is open in the The University of Texas Medical Branch, Galveston pipeline

29 recruiting of 203 indexed (14% open); 117 completed (58%).

Phase mix: 19 late (III/IV) vs 51 early (I/II) (early-phase heavy).

Top condition: Stroke (4 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

The University of Texas Medical Branch, Galveston: open-pipeline peers nationwide

Peers matched on 203 registered trials and 14% open enrollment, not the therapeutic-area sidebar.

The University of Texas Medical Branch, Galveston sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 050100150200250 0%5%10%15%20% Total trials Recruiting share The University of Texas Medical Branch, GalvestonNational Center for Complementary and Integrative Health (NCCIH)MedImmuneGenzyme, a Sanofi CompanyOHSU Knight Cancer InstituteAcademic and Community Cancer Research UnitedAdaptive BiotechnologiesAgelessRxAlaska Blind Child Discovery
The University of Texas Medical Branch, Galveston sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

The University of Texas Medical Branch, Galveston sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 203 trials (± recruiting share)

Sponsors near 14% open enrollment (± trial volume)

What to do with this The University of Texas Medical Branch, Galveston page

203 registered trials is a research-attention snapshot, not an endorsement of The University of Texas Medical Branch, Galveston or any single study.

  • 29 of The University of Texas Medical Branch, Galveston's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Stroke is the condition The University of Texas Medical Branch, Galveston studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Stroke trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. The University of Texas Medical Branch, Galveston pipeline card: 203 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.